Salarius Pharmaceuticals, Inc. (DCOY)
NASDAQ · Healthcare
Salarius Pharmaceuticals, Inc. Operating Income 2015–2022
Salarius Pharmaceuticals, Inc. annual/quarterly operating income history and growth rate from 2015 to 2023. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Salarius Pharmaceuticals, Inc. operating income for the quarter ending March 31, 2023 was -5.4 M, a 11.39% decrease year-over-year.
- Salarius Pharmaceuticals, Inc. operating income for the twelve months ending March 31, 2023 was -30.8 M, a 195.24% increase year-over-year.
- Salarius Pharmaceuticals, Inc. annual operating income for 2022 was -31.8 M, a 148.51% increase from 2021.
- Salarius Pharmaceuticals, Inc. annual operating income for 2021 was -12.8 M, a 64.56% increase from 2020.
- Salarius Pharmaceuticals, Inc. annual operating income for 2020 was -7.8 M, a 5.79% decrease from 2019.
- Salarius Pharmaceuticals, Inc. annual operating income for 2019 was -8.3 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Salarius Pharmaceuticals, Inc. Operating Income — FAQ
Salarius Pharmaceuticals, Inc. (DCOY) operating income over the last 8 years — annual and quarterly figures with year-over-year growth and charts.
What is Salarius Pharmaceuticals, Inc.'s operating income?
Salarius Pharmaceuticals, Inc. (DCOY) reported operating income of -$32M for fiscal 2022.
Where can I see DCOY's operating income history?
The chart and table above show Salarius Pharmaceuticals, Inc.'s operating income by year and by quarter, including the growth rate.